TRENTON, N.J. (AP) -- A new type of osteoporosis drug being developed by Merck & Co. increased bone density over two years in postmenopausal women with mild osteoporosis, the company reported Tuesday....
merckNew Merck osteoporosis drug boosts bone densityHeadlines from the Associated Press Tue, 09/16/2008 - 12:06
TRENTON, N.J. (AP) -- A new type of osteoporosis drug being developed by Merck & Co. increased bone density over two years in postmenopausal women with mild osteoporosis, the company reported Tuesday.... Merck ends study of cholesterol drugHeadlines from the Associated Press Wed, 05/21/2008 - 15:37
TRENTON, N.J. (AP) -- Merck & Co. has halted a study of an experimental drug it had touted as key to energizing its sagging cholesterol franchise, barely three weeks after U.S. regulators refused to allow sales of the drug.... Newspaper: FDA found concerns at Merck vaccine plantHeadlines from the Associated Press Thu, 04/24/2008 - 17:29
TRENTON, N.J. (AP) -- Contaminated children's vaccines and other potentially serious concerns were spotted by federal regulators who combed Merck & Co.'s vaccine plant in the Philadelphia suburbs, according to a published report.... Reports Allege Merck Misrepresented Vioxx Researchwashingtonpost.com - Health Tue, 04/15/2008 - 16:17
Two teams of researchers with access to thousands of documents gathered in lawsuits over the painkiller Vioxx allege that Merck & Co. waged a campaign of deception to promote its drug, moving slowly to warn of possible hazards while dressing up in-house research as the work of independent academic... Dems Question Timing of Vytorin PapersHeadlines from the Associated Press Fri, 04/11/2008 - 15:38
WASHINGTON (AP) -- House Democrats are questioning whether Merck and Schering-Plough made up information about a meeting of medical experts to discuss Vytorin, after lawmakers began investigating a failed study of the drug.... Rising Australian biotech stars set to connect on the world stag...EurekAlert! - Medicine and Health Sat, 03/29/2008 - 23:00
Two of Australia's leading life scientists have been chosen from a highly competitive field of candidates to take part in an initiative by Merck Sharp & Dohme and Advance to boost the capability of the country's burgeoning biopharmaceutical industry. FDA: Merck Drug May Have Suicide LinkHeadlines from the Associated Press Thu, 03/27/2008 - 11:43
WASHINGTON (AP) -- The Food and Drug Administration said Thursday it is investigating a possible link between Merck's allergy drug Singulair and suicide.... Rising Australian biotech stars set to connect on the world stag...EurekAlert! - Medicine and Health Tue, 03/25/2008 - 23:00
Two of Australia's leading life scientists have been chosen from a highly competitive field of candidates to take part in an initiative by Merck Sharp & Dohme and Advance to boost the capability of the country's burgeoning biopharmaceutical industry. |